Literature DB >> 20173200

Adaptation of a hyperthermophilic group II chaperonin to relatively moderate temperatures.

Taro Kanzaki1, Shuzo Ushioku, Ayumi Nakagawa, Toshihiko Oka, Kazunobu Takahashi, Takashi Nakamura, Kunihiro Kuwajima, Akihiko Yamagishi, Masafumi Yohda.   

Abstract

Group II chaperonins exist in archaea and the eukaryotic cytosol, and mediate protein folding in an ATP-dependent manner. We have been studying the reaction mechanism of group II chaperonins using alpha chaperonin, the recombinant chaperonin alpha subunit homo-oligomer from a hyperthermophilic archaeon, Thermococcus sp. strain KS-1 (T. KS-1). Although the high stability and activity of T. KS-1 alpha chaperonin provided advantages for our study, its high thermophilicity caused the difficulty in using various analytical methods. To resolve this problem, we tried to adapt T. KS-1 alpha chaperonin to moderate temperatures by mutations. The comparison of amino acid sequences between 26 thermophilic and 17 mesophilic chaperonins showed that three amino acid replacements are likely responsible for the difference of their optimal temperatures. We introduced three single mutations and also their double combinations into T. KS-1 alpha chaperonin. Among them, K323R single mutant exhibited the improvements of the folding activity and the ATP-dependent conformational change ability at lower temperatures, such as 50 degrees C and 40 degrees C. Since K323 may secure helix 12 in the closed conformation by interacting with D198, the replacement of Lys to Arg likely induced the higher mobility of the built-in lid, resulting in the higher activity at relatively low temperatures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173200     DOI: 10.1093/protein/gzq010

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  1 in total

1.  Characterization of group II chaperonins from an acidothermophilic archaeon Picrophilus torridus.

Authors:  Yohei Y Yamamoto; Kanako Tsuchida; Keiichi Noguchi; Naoki Ogawa; Hiroshi Sekiguchi; Yuji C Sasaki; Masafumi Yohda
Journal:  FEBS Open Bio       Date:  2016-06-14       Impact factor: 2.693

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.